You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -71,250.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.0 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 1,036.3 | n/a |
Price / Book value | 1.7 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | n/a | -0.95 | -0.87p | -3.2 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | n/a | -1.57 | -0.96p | -8.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | n/a | -1.84 | -0.85p | -5.2 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -1.19 | -0.55p | -3.4 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 0.00 | -1.42 | -0.52p | -1.6 | 0.0 | n/a | n/a | 0.0% |
N4 Pharma files for new UK patent Sharecast News | 04 Dec |
---|---|
N4 Pharma reports positive progress with SRI collaboration Sharecast News | 20 Aug |
N4 Pharma shares tank after £0.6m fundraise Sharecast News | 07 Jun |
N4 101 In Vitro Results | 12-Dec-24 07:01 |
---|---|
New Patent Filing | 04-Dec-24 07:01 |
Grant of Options | 28-Nov-24 07:01 |
Interim Results | 24-Sep-24 07:01 |